Optimization of PEEP for Alveolar Recruitment in ARDS
OPERA
1 other identifier
observational
22
1 country
1
Brief Summary
Actual setting of PEEP in ARDS is based on tables linked to FiO2, or respiratory system plateau pressure (e.g EXPRESS Study) or set regarding esophageal pressure mesurement and transpulmonary pressure calculation. Opera study should confirm if a setting approach based on esophageal pressure is helpfull for any ARDS patient in ICU without deleterious side-effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 19, 2013
CompletedFirst Posted
Study publicly available on registry
September 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedJune 27, 2016
June 1, 2016
2.5 years
September 19, 2013
June 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PaO2/FiO2 ratio
24 hours
Secondary Outcomes (1)
Vd/Vt ratio
24 hours
Study Arms (1)
ARDS
ARDS patients achieving stades II and III of Berlin 2011 Classification
Interventions
"EXPRESS study" ventilatory setting the optimization of PEEP with esophageal pressure mesurement
Eligibility Criteria
All ICU patients achievinf definition of ARDS stades II and III of Berlin Classification
You may qualify if:
- ARDS Stades 2 and 3 with invasive ventilation (EXPRESS settings) within 3 to 12 hours
You may not qualify if:
- less 18 years, pregnancy, intracardiac shunt, esophageal catheter cons-indicated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital of Melunlead
- Melun Hospital Intensive Care Unitcollaborator
Study Sites (1)
Melun Hospital ICU
Melun, 77000, France
Study Officials
- STUDY DIRECTOR
Mehran Monchi, MD
Melun Hospital ICU
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 19, 2013
First Posted
September 24, 2013
Study Start
September 1, 2013
Primary Completion
March 1, 2016
Study Completion
May 1, 2016
Last Updated
June 27, 2016
Record last verified: 2016-06